1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe

RxCUI: 1000153
RxNorm name: 1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe
Display name: medroxyPROGESTERone (Injectable)
Full name: 1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe
Term type: SCD
Status: Active
Strength: 150 mg/ml
Dose form: Prefilled Syringe 1 ml
Route: Injectable
Updated: 2026-10-21 07:26:50

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 092010
Active start: 092010
Multiple ingredient: NO
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
medroxyprogesterone acetate	150 MG / 1 ML	medroxyprogesterone	medroxyprogesterone acetate

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Prefilled Syringe	721656

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
medroxyprogesterone	6691

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	1 ML medroxyPROGESTERone acetate 150 MG/ML Prefilled Syringe	1	NAMES
RxNorm Name	1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe	1	NAMES
RxNorm Synonym	medroxyprogesterone acetate 150 MG per 1 ML Prefilled Syringe	1	NAMES
TTY	SCD	1	ATTRIBUTES
SPL_SET_ID	7 linked values 01e28bef-9758-40cf-a4ff-86ae9f4f5105 6457d70a-2f25-4935-8511-726d988f7a03 0655670a-d127-4e08-8a23-ace64b2503b2 987496bf-b4b0-409b-b745-f52ed0871f4e a0a92717-c1cb-40eb-a95a-1c5dfd32cfc0 ca344c55-5251-470f-9243-eceb9e496e3e fda1aa8a-5739-482a-b4f6-9741ef4d9977	7	CODES
RxCUI	1000153	1	CODES
MMSL_CODE	MTH_RXN_BD1843	1	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
0548-5701-00	0548-5701	Medroxyprogesterone Acetate Medroxyprogesterone acetate	Amphastar Pharmaceuticals, Inc.	ANDA077334
50090-5925-0	50090-5925	medroxyprogesterone acetate medroxyprogesterone acetate	A-S Medication Solutions	NDA020246
55150-330-01	55150-330	MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE	Eugia US LLC	ANDA212844
62756-091-40	62756-091	MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE	Sun Pharmaceutical Industries, Inc.	ANDA210761
66993-371-79	66993-371	medroxyprogesterone acetate medroxyprogesterone acetate	Prasco Laboratories	NDA020246
70121-1480-1	70121-1480	medroxyprogesterone acetate medroxyprogesterone acetate	Amneal Pharmaceuticals LLC	ANDA215397
70518-4324-0	70518-4324	medroxyprogesterone acetate medroxyprogesterone acetate	REMEDYREPACK INC.	ANDA215397

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
ANDA077334	0548-5701	Medroxyprogesterone Acetate Medroxyprogesterone acetate	ANDA	Amphastar Pharmaceuticals, Inc.
NDA020246	50090-5925	medroxyprogesterone acetate medroxyprogesterone acetate	NDA AUTHORIZED GENERIC	A-S Medication Solutions
ANDA212844	55150-330	MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE	ANDA	Eugia US LLC
ANDA210761	62756-091	MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE	ANDA	Sun Pharmaceutical Industries, Inc.
ANDA215397	70121-1480	medroxyprogesterone acetate medroxyprogesterone acetate	ANDA	Amneal Pharmaceuticals LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 30 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
00548570100	rxnav_ndcs	yes
00548571100	rxnav_ndcs	yes
16714099901	rxnav_ndcs	yes
50090332800	rxnav_ndcs	yes
50090574700	rxnav_ndcs	yes
50090592500	rxnav_ndcs	yes
50102059140	rxnav_ndcs	yes
55150033001	rxnav_ndcs	yes
59762453802	rxnav_ndcs	yes
62756009140	rxnav_ndcs	yes
66993037179	rxnav_ndcs	yes
70121148001	rxnav_ndcs	yes
70518432400	rxnav_ndcs	yes
00009737606	rxnav_historical_indirect
00009737698	rxnav_historical_indirect
00009737699	rxnav_historical_indirect
00703681121	rxnav_historical
50090066500	rxnav_historical
52125091501	rxnav_historical
54868410000	rxnav_historical_indirect
54868410001	rxnav_historical_indirect
59267737601	rxnav_historical_indirect
59267737602	rxnav_historical_indirect
59267737603	rxnav_historical_indirect
59267737604	rxnav_historical_indirect
59762453801	rxnav_historical
59762453809	rxnav_historical
70518193200	rxnav_historical
70518333600	rxnav_historical
70518389900	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
medroxyprogesterone acetate	MEDROXYPROGESTERONE ACETATE	REMEDYREPACK INC.	a0a92717-c1cb-40eb-a95a-1c5dfd32cfc0	2026-09-04	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 70518-4324-0 ndc (product): 70518-4324 ndc11 (package): 70518432400 rxcui: 1000153
medroxyprogesterone acetate	MEDROXYPROGESTERONE ACETATE	Prasco Laboratories	987496bf-b4b0-409b-b745-f52ed0871f4e	2026-08-25	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 66993-371-79 ndc (product): 66993-371 ndc11 (package): 66993037179 rxcui: 1000153
Depo-Provera	MEDROXYPROGESTERONE ACETATE	Pharmacia & Upjohn Company LLC	199cf13e-0859-4a73-9b45-e700d0cd1049	2026-08-25	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1000153
medroxyprogesterone acetate	MEDROXYPROGESTERONE ACETATE	Amneal Pharmaceuticals LLC	6457d70a-2f25-4935-8511-726d988f7a03	2026-01-19	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 70121-1480-1 ndc (product): 70121-1480 ndc11 (package): 70121148001 rxcui: 1000153
MEDROXYPROGESTERONE ACETATE	MEDROXYPROGESTERONE ACETATE	Eugia US LLC	0655670a-d127-4e08-8a23-ace64b2503b2	2026-01-08	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 55150-330-01 ndc (product): 55150-330 ndc11 (package): 55150033001 rxcui: 1000153
Medroxyprogesterone Acetate	MEDROXYPROGESTERONE ACETATE	Amphastar Pharmaceuticals, Inc.	fda1aa8a-5739-482a-b4f6-9741ef4d9977	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 0548-5701-00 ndc (product): 0548-5701 ndc11 (package): 00548570100 rxcui: 1000153
medroxyprogesterone acetate	MEDROXYPROGESTERONE ACETATE	A-S Medication Solutions	ca344c55-5251-470f-9243-eceb9e496e3e	2023-10-23	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 50090-5925-0 ndc (product): 50090-5925 ndc11 (package): 50090592500 rxcui: 1000153
MEDROXYPROGESTERONE ACETATE	MEDROXYPROGESTERONE ACETATE	Sun Pharmaceutical Industries, Inc.	01e28bef-9758-40cf-a4ff-86ae9f4f5105	2022-12-14	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 62756-091-40 ndc (product): 62756-091 ndc11 (package): 62756009140 rxcui: 1000153

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 9 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
199cf13e-0859-4a73-9b45-e700d0cd1049	medroxyPROGESTERone acetate 150 MG in 1 ML Prefilled Syringe [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Prefilled Syringe [SY]	3	28	These highlights do not include all the information needed to use DEPO-PROVERA CI safely and effectively. See full prescribing information for DEPO-PROVERA CI. DEPO-PROVERA CI (medroxyprogesterone acetate) injectable suspension, for intramuscular use Initial U.S. Approval: 1959	20251218
987496bf-b4b0-409b-b745-f52ed0871f4e	medroxyPROGESTERone acetate 150 MG in 1 ML Prefilled Syringe [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Prefilled Syringe [SY]	3	10	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	20260107
6457d70a-2f25-4935-8511-726d988f7a03	medroxyPROGESTERone acetate 150 MG in 1 ML Prefilled Syringe [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Prefilled Syringe [SY]	3	7	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	20260119
01e28bef-9758-40cf-a4ff-86ae9f4f5105	medroxyPROGESTERone acetate 150 MG in 1 ML Prefilled Syringe [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Prefilled Syringe [SY]	3	7	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	20221214
8ad58c4b-c263-4562-92cd-b1f81f3e06b3	medroxyPROGESTERone acetate 150 MG in 1 ML Prefilled Syringe [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Prefilled Syringe [SY]	3	6	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	20180814
ca344c55-5251-470f-9243-eceb9e496e3e	medroxyPROGESTERone acetate 150 MG in 1 ML Prefilled Syringe [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Prefilled Syringe [SY]	3	5	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	20231023
0655670a-d127-4e08-8a23-ace64b2503b2	medroxyPROGESTERone acetate 150 MG in 1 ML Prefilled Syringe [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Prefilled Syringe [SY]	3	4	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	20260108
a0a92717-c1cb-40eb-a95a-1c5dfd32cfc0	medroxyPROGESTERone acetate 150 MG in 1 ML Prefilled Syringe [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Prefilled Syringe [SY]	3	2	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	20251002
e364a31e-8926-4bda-b00e-efb097bd3830	medroxyPROGESTERone acetate 150 MG in 1 ML Prefilled Syringe [PSN] · 1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe [SCD] · medroxyprogesterone acetate 150 MG per 1 ML Prefilled Syringe [SY]	3	2	These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	20221220

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
a0a92717-c1cb-40eb-a95a-1c5dfd32cfc0	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	REMEDYREPACK INC.	20260904
987496bf-b4b0-409b-b745-f52ed0871f4e	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	Prasco Laboratories \| Pharmacia & Upjohn Company LLC \| Pfizer Manufacturing Belgium NV	20260825
987496bf-b4b0-409b-b745-f52ed0871f4e	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	Prasco Laboratories \| Pharmacia & Upjohn Company LLC \| Pfizer Manufacturing Belgium NV	20260721
6457d70a-2f25-4935-8511-726d988f7a03	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Amneal Pharmaceuticals LLC \| Amneal Pharmaceuticals of New York, LLC \| Laboratorios Farmalan, S.A.	20260119
0655670a-d127-4e08-8a23-ace64b2503b2	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Eugia US LLC \| EUGIA Pharma Specialities Limited	20260108
987496bf-b4b0-409b-b745-f52ed0871f4e	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	Prasco Laboratories \| Pharmacia & Upjohn Company LLC \| Pfizer Manufacturing Belgium NV	20260107
fda1aa8a-5739-482a-b4f6-9741ef4d9977	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Amphastar Pharmaceuticals, Inc.	20260101
a0a92717-c1cb-40eb-a95a-1c5dfd32cfc0	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	REMEDYREPACK INC.	20251002
bbdf320e-4cb3-4f33-b0a8-526831994862	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Eugia US LLC \| EUGIA Pharma Specialities Limited	20241009
428481bb-b7cf-4d76-b57d-0d6bfa2b6ac3	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	Greenstone LLC \| Pfizer Manufacturing Belgium NV \| Pharmacia & Upjohn Company LLC	20240816
f3b79790-abd0-4530-acd8-a5253a4f61cd	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	REMEDYREPACK INC.	20240403
0383ce6b-2137-4bf3-a00e-a116916250a6	These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	REMEDYREPACK INC.	20240315
ca344c55-5251-470f-9243-eceb9e496e3e	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	A-S Medication Solutions	20231023
d415e7cc-0756-4c70-803f-011133a6b731	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	A-S Medication Solutions	20230206
e7cdee68-8d8f-411d-bc65-ddbf31866369	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	A-S Medication Solutions	20230206
e364a31e-8926-4bda-b00e-efb097bd3830	These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Amphastar Pharmaceuticals, Inc.	20221220
f7629f1b-602d-47f9-947d-7ec5bc4ac8d0	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	NorthStar RxLLC \| Sun Pharmaceutical Industries, Inc. \| Sun Pharmaceutical Industries Limited	20221214
01e28bef-9758-40cf-a4ff-86ae9f4f5105	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Sun Pharmaceutical Industries, Inc. \| Sun Pharmaceutical Industries Limited	20221214
908573ce-d494-4f7f-95ae-6edbc4e4c5dc	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Afaxys Pharma, LLC \| Sun Pharmaceutical Industries, Inc. \| Sun Pharmaceutical Industries Limited	20221214
fda1aa8a-5739-482a-b4f6-9741ef4d9977	These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959	Amphastar Pharmaceuticals, Inc.	20211213
d21979ec-271f-4e4a-8d4d-d561b8a0f563	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	REMEDYREPACK INC.	20210622
c91f0af4-1411-4ab6-8b3c-b8dcfa56a9b7	These highlights do not include all the information needed to use DEPO-PROVERA CI safely and effectively. See full prescribing information for DEPO-PROVERA CI. DEPO-PROVERA CI (medroxyprogesterone acetate) injectable suspension, for intramuscular use Initial U.S. Approval: 1959	A-S Medication Solutions	20200219
8ad58c4b-c263-4562-92cd-b1f81f3e06b3	These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP safely and effectively. See full prescribing information for MPA INJECTABLE SUSPENSION, USP. MEDROXYPROGESTERONE ACETATE (MPA) Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959	REMEDYREPACK INC.	20180814
06ffa173-f68e-405d-8dd0-78eaa2e3dd44		National Council for Prescription Drug Programs	20130303
982417ac-cda6-4015-b1ff-27c2f9286548		National Council for Prescription Drug Programs	20130213
9f0ac808-3768-4f74-95ed-95fa1b27f58e		National Council for Prescription Drug Programs	20120724
5de51187-690f-4cc2-91be-66867b817d97		National Council for Prescription Drug Programs	20120724
fdb47ab8-b0b3-4f05-a539-c17df63e843a		National Council for Prescription Drug Programs	20120724

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	G03DA	Pregnen (4) derivatives	ATC1-4		medroxyprogesterone
ATC	L02AB	Progestogens	ATC1-4		medroxyprogesterone
ATC	G03AC	Progestogens	ATC1-4		medroxyprogesterone
FDASPL	D045167	Progesterone Congeners	CHEM	has_chemical_structure	medroxyprogesterone
FDASPL	N0000175602	Progestin	EPC	has_epc	medroxyprogesterone
MEDRT	D008525	Medroxyprogesterone	CHEM	has_ingredient	medroxyprogesterone
MEDRT	D017258	Medroxyprogesterone Acetate	CHEM	has_ingredient	medroxyprogesterone acetate
MEDRT	D000568	Amenorrhea	DISEASE	may_treat	medroxyprogesterone acetate
MEDRT	D000568	Amenorrhea	DISEASE	may_treat	medroxyprogesterone
MEDRT	D001943	Breast Neoplasms	DISEASE	may_treat	medroxyprogesterone
MEDRT	D001943	Breast Neoplasms	DISEASE	ci_with	medroxyprogesterone
MEDRT	D001943	Breast Neoplasms	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D001943	Breast Neoplasms	DISEASE	may_treat	medroxyprogesterone acetate
MEDRT	D002292	Carcinoma, Renal Cell	DISEASE	may_treat	medroxyprogesterone acetate
MEDRT	D002292	Carcinoma, Renal Cell	DISEASE	may_treat	medroxyprogesterone
MEDRT	D002543	Cerebral Hemorrhage	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D002543	Cerebral Hemorrhage	DISEASE	ci_with	medroxyprogesterone
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	medroxyprogesterone
MEDRT	D004714	Endometrial Hyperplasia	DISEASE	may_treat	medroxyprogesterone acetate
MEDRT	D004714	Endometrial Hyperplasia	DISEASE	may_treat	medroxyprogesterone
MEDRT	D016889	Endometrial Neoplasms	DISEASE	may_treat	medroxyprogesterone
MEDRT	D016889	Endometrial Neoplasms	DISEASE	may_treat	medroxyprogesterone acetate
MEDRT	D006470	Hemorrhage	DISEASE	ci_with	medroxyprogesterone
MEDRT	D006470	Hemorrhage	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D007040	Hypoventilation	DISEASE	may_treat	medroxyprogesterone
MEDRT	D007040	Hypoventilation	DISEASE	may_treat	medroxyprogesterone acetate
MEDRT	D008107	Liver Diseases	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D008107	Liver Diseases	DISEASE	ci_with	medroxyprogesterone
MEDRT	D009376	Neoplasms, Hormone-Dependent	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D009376	Neoplasms, Hormone-Dependent	DISEASE	ci_with	medroxyprogesterone
MEDRT	D011247	Pregnancy	DISEASE	may_prevent	medroxyprogesterone acetate
MEDRT	D011247	Pregnancy	DISEASE	may_prevent	medroxyprogesterone
MEDRT	D011247	Pregnancy	DISEASE	ci_with	medroxyprogesterone
MEDRT	D011247	Pregnancy	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D011655	Pulmonary Embolism	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D011655	Pulmonary Embolism	DISEASE	ci_with	medroxyprogesterone
MEDRT	D013924	Thrombophlebitis	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D013924	Thrombophlebitis	DISEASE	ci_with	medroxyprogesterone
MEDRT	D014592	Uterine Hemorrhage	DISEASE	ci_with	medroxyprogesterone
MEDRT	D014592	Uterine Hemorrhage	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D014592	Uterine Hemorrhage	DISEASE	may_treat	medroxyprogesterone acetate
MEDRT	D014592	Uterine Hemorrhage	DISEASE	may_treat	medroxyprogesterone
MEDRT	D014623	Vaginal Diseases	DISEASE	ci_with	medroxyprogesterone
MEDRT	D014623	Vaginal Diseases	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	D020246	Venous Thrombosis	DISEASE	ci_with	medroxyprogesterone
MEDRT	D020246	Venous Thrombosis	DISEASE	ci_with	medroxyprogesterone acetate
MEDRT	N0000000185	Progestational Hormone Receptor Agonists	MOA	has_moa	medroxyprogesterone acetate
MEDRT	N0000000185	Progestational Hormone Receptor Agonists	MOA	has_moa	medroxyprogesterone
MEDRT	N0000008630	Decreased Follicle Stimulating Hormone Secretion	PE	has_pe	medroxyprogesterone acetate
MEDRT	N0000008630	Decreased Follicle Stimulating Hormone Secretion	PE	has_pe	medroxyprogesterone
MEDRT	N0000008632	Decreased Growth Hormone Secretion	PE	has_pe	medroxyprogesterone acetate
MEDRT	N0000008632	Decreased Growth Hormone Secretion	PE	has_pe	medroxyprogesterone
MEDRT	N0000009051	Gonadotropin Releasing Hormone Alteration	PE	has_pe	medroxyprogesterone acetate
MEDRT	N0000009051	Gonadotropin Releasing Hormone Alteration	PE	has_pe	medroxyprogesterone
MEDRT	N0000009715	Inhibit Ovarian Follicular Phase	PE	has_pe	medroxyprogesterone acetate
MEDRT	N0000009715	Inhibit Ovarian Follicular Phase	PE	has_pe	medroxyprogesterone
MEDRT	N0000009717	Inhibit Ovulation	PE	has_pe	medroxyprogesterone acetate
MEDRT	N0000009717	Inhibit Ovulation	PE	has_pe	medroxyprogesterone
MEDRT	N0000009857	Stimulate Breast Glandular Development	PE	has_pe	medroxyprogesterone acetate
MEDRT	N0000009857	Stimulate Breast Glandular Development	PE	has_pe	medroxyprogesterone
MEDRT	N0000000043	Hepatic Excretion	PK	has_pk	medroxyprogesterone
MEDRT	N0000000043	Hepatic Excretion	PK	has_pk	medroxyprogesterone acetate
MEDRT	N0000000026	Hepatic Metabolism	PK	has_pk	medroxyprogesterone
MEDRT	N0000000026	Hepatic Metabolism	PK	has_pk	medroxyprogesterone acetate
MEDRT	N0000000042	Renal Excretion	PK	has_pk	medroxyprogesterone
MEDRT	N0000000042	Renal Excretion	PK	has_pk	medroxyprogesterone acetate

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Depo-Provera	rxnav_allrelated
DF	DF	Prefilled Syringe	rxnav_allrelated
DFG	DFG	Injectable Product	rxnav_allrelated
IN	IN	medroxyprogesterone	rxnav_allrelated
PIN	PIN	medroxyprogesterone acetate	rxnav_allrelated
SBD	SBD	1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe [Depo-Provera]	rxnav_allrelated
SBDC	SBDC	medroxyprogesterone acetate 150 MG/ML [Depo-Provera]	rxnav_allrelated
SBDF	SBDF	medroxyprogesterone Prefilled Syringe [Depo-Provera]	rxnav_allrelated
SBDFP	SBDFP	medroxyprogesterone acetate Prefilled Syringe [Depo-Provera]	rxnav_allrelated
SBDG	SBDG	Depo-Provera Injectable Product	rxnav_allrelated
SCD	SCD	1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe	rxnav_allrelated
SCDC	SCDC	medroxyprogesterone acetate 150 MG/ML	rxnav_allrelated
SCDF	SCDF	medroxyprogesterone Prefilled Syringe	rxnav_allrelated
SCDFP	SCDFP	medroxyprogesterone acetate Prefilled Syringe	rxnav_allrelated
SCDG	SCDG	medroxyprogesterone Injectable Product	rxnav_allrelated
SCDGP	SCDGP	medroxyprogesterone acetate Injectable Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	150 MG/ML (expressed as medroxyprogesterone acetate)
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	QUANTITY	1 ML
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
CODES	ANDA	ANDA077334
CODES	ANDA	ANDA210761
CODES	ANDA	ANDA212844
CODES	ANDA	ANDA215397
CODES	VUID	4002358
NAMES	Prescribable Synonym	medroxyPROGESTERone acetate 150 MG in 1 ML Prefilled Syringe
NAMES	Tallman Synonym	1 ML medroxyPROGESTERone acetate 150 MG/ML Prefilled Syringe
NAMES	Tallman Synonym	medroxyPROGESTERone acetate 150 MG per 1 ML Prefilled Syringe
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Metathesaurus FDA Structured Product Labels
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	Multum MediSource Lexicon
SOURCES	Source	National Drug Data File Plus Source Vocabulary
SOURCES	Source	Veterans Health Administration National Drug File